As many of you know, one of the many business deals I’ve been following is the Wellspring Clinical Lab Inc deal. Thanks to breakthrough technology, the hundreds of blood tests which currently cost $200 in a doctor’s office will soon be available to the consumer for the cost of about $35 in the comfort of their own home.
This deal was recently published in a magazine (The Elevator) which specifically targets investors and features a variety of business deals from all around the globe.
“The Elevator… probably the world’s only investment magazine that combines accessible private equity deals with luxury features and philanthropy. The Elevator holds a well of opportunity in business and leisure.”
Featured in this magazine’s summer issue is Wellspring Clinical Lab’s breakthrough in blood testing technology, guaranteed to make a splash in the world of healthcare and medicine.
The Elevator magazine is a modern, international financial publication featuring private equity opportunities from throughout the globe. The magazine focuses on forward-looking industries, including consumer Internet, software, hardware, clean-tech, bio-tech and health care.
Catering specifically to investors, The Elevator is distributed in print form throughout the United States, United Kingdom, Germany and Switzerland. It is also available in electronic form to anyone with Internet access.
This degree of publicity indicates Wellspring has reached a new level of popularity. I believe they are still seeking funding at this point and this is a great way to put money into something which is poised for growth and great returns, unlike the currently volatile stock market.